赛托瑞疗法(CYTX)

0.2077 0.0000 0.0%

今开:0.0昨收:0.2077
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:4601759.0

赛托瑞疗法的热门评论

赛托瑞疗法(CYTX)2019-08-15 11:50

$赛托瑞疗法(CYTX)$ NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB Filed: 2019-08-14 AccNo: 0001564590-19-032183 Size: 63 KB 网页链接查看全文

赛托瑞疗法(CYTX)2019-08-10 05:10

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-09 AccNo: 0001564590-19-031278 Size: 32 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接查看全文

赛托瑞疗法(CYTX)2019-08-03 04:15

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-02 AccNo: 0001564590-19-028357 Size: 35 KBItem 7.01: Regulation FD Disclosure 网页链接查看全文

赛托瑞疗法(CYTX)2019-08-16 05:40

$赛托瑞疗法(CYTX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-15 AccNo: 0001564590-19-032349 Size: 6 MB 网页链接查看全文

赛托瑞疗法(CYTX)2019-07-29 20:20

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-29 AccNo: 0001564590-19-026454 Size: 249 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接查看全文

静心成佛2019-08-02 22:43

$赛托瑞疗法(CYTX)$ 发生什么了?查看全文

赛托瑞疗法(CYTX)2019-08-06 20:15

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-06 AccNo: 0001564590-19-028996 Size: 53 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接查看全文

赛托瑞疗法(CYTX)2019-07-23 20:20

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-23 AccNo: 0001564590-19-025505 Size: 37 KBItem 1.02: Termination of a Material Definitive Agreement 网页链接查看全文

赛托瑞疗法(CYTX)2019-06-28 06:10

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-06-27 AccNo: 0001564590-19-023871 Size: 39 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68

赛托瑞疗法的最新评论

szmayun2014-03-08 20:31

回复@龙亮: 我是看到牛兄贴出的资料才关注赛托瑞的,感谢牛兄[很赞]//@龙亮:回复@szmayun:和你们站在一起不孤单查看全文

LP06282014-03-06 22:53

$赛托瑞医疗(CYTX)$ 继续磨唧吧!查看全文

szmayun2014-03-06 21:21

回复@牛得草: 基础平台在赛托瑞这里,运用越广,价值越大//@牛得草:回复@szmayun:已经有项目申报了,属于资助性质的,申报是靠当地科研机构,现在研究的治疗尿失禁,肾病,糖尿病查看全文

LP06282014-03-06 20:33

$赛托瑞医疗(CYTX)$ 预测-0.12 各位怎么看?查看全文

szmayun2014-03-06 20:19

回复@牛得草: 基于赛托瑞的设备所产生的脂肪干细胞,与世界上60多家机构合作研发新用途,这是何其大的一个平台啊,赛托瑞的想象空间太大了//@牛得草:回复@szmayun:现在赛托瑞在全世界和60多家机构合作研发基于他设备所产生的脂肪干细胞的新用途,还有许多在临床前和临床中的项目,需要逐一临床逐一...查看全文

szmayun2014-03-06 17:13

回复@LP0628: 我是看基本面的,具体到赛托瑞目前阶段,就是牛兄说的看项目进展。在项目有实质性推进前提下,斗胆从技术上展望一下:短期看5.16,中期看7.86。//@LP0628:回复@szmayun:技术要求到时间了!查看全文

szmayun2014-03-06 14:40

$赛托瑞医疗(CYTX)$ 昨晚分别以3.29、3.20共买入10460股。查看全文

牛得草2014-03-06 13:50

$赛托瑞医疗(CYTX)$ 成人脂肪干细胞创造惊人奇迹 纽曼医学博士抗老化使用范围见证网页链接查看全文

牛得草2014-03-06 12:05

回复@szmayun: 现在赛托瑞在全世界和60多家机构合作研发基于他设备所产生的脂肪干细胞的新用途,还有许多在临床前和临床中的项目,需要逐一临床逐一审批,需要耗费大量资金,这些一旦成功推向市场,咱们将见证奇迹。//@szmayun:回复@牛得草:FDA核准之日,赛托瑞腾飞之时[献花花]查看全文

szmayun2014-03-06 11:58

回复@牛得草: FDA核准之日,赛托瑞腾飞之时[献花花]//@牛得草:回复@LP0628:明年结束慢性心脏病二期后查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68

赛托瑞疗法的公告

$赛托瑞疗法(CYTX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-15 AccNo: 0001564590-19-032349 Size: 6 MB 网页链接

$赛托瑞疗法(CYTX)$ NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB Filed: 2019-08-14 AccNo: 0001564590-19-032183 Size: 63 KB 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-09 AccNo: 0001564590-19-031278 Size: 32 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-06 AccNo: 0001564590-19-028996 Size: 53 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-02 AccNo: 0001564590-19-028357 Size: 35 KBItem 7.01: Regulation FD Disclosure 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-29 AccNo: 0001564590-19-026454 Size: 249 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-23 AccNo: 0001564590-19-025505 Size: 37 KBItem 1.02: Termination of a Material Definitive Agreement 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-16 AccNo: 0001564590-19-025075 Size: 57 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-11 AccNo: 0001564590-19-024844 Size: 64 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission o...

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-05 AccNo: 0001564590-19-024571 Size: 40 KBItem 2.05: Cost Associated with Exit or Disposal ActivitiesItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensat...

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37